MOTOHEALTH uses FDA-approved body sensors to transmit data about the patient's condition to the health care provider via the patient's Motorola mobile phone. This convenient and discreet way of monitoring patients in the mobile environment may replace in-home monitoring devices, giving chronic disease patients more independence to continue their daily activities outside their homes.
"Chronic diseases such as diabetes and obesity have reached epidemic proportions in the United States", stated Dr. Joseph C. Kvedar, M.D., corporate director, Partners Telemedicine; president, American Telemedicine Association; and vice chair, Dermatology, Harvard Medical School, who serves as the Principal Investigator on this clinical trial. "Medical studies have indicated that daily monitoring helps patients with chronic diseases to maintain appropriate drug, diet and exercise regimens. By focusing on diseases that can be managed with proper prevention and that account for the majority of health care costs, MOTOHEALTH could lower health care spending by managing chronic diseases before they get to the point where excessive spending is necessary for treatment."
"The MOTOHEALTH solution, when implemented into a comprehensive health care programme, can give health care providers useful, daily updates on a patient's physiological levels such as blood pressure, glucose level, and weight", stated Jay Pieper, vice-president of corporate development and treasury affairs, Partners Healthcare Inc. "This facilitates pro-active treatment action, resulting in fewer hospitalizations and visits to emergency rooms, potentially lowering health care costs."
"Motorola's vision for the MOTOHEALTH project is to push health care out of high-cost facilities and to the patient, enabling the body to become the point of care", stated Peter Aloumanis, director, United States Markets Division, Motorola's iDEN Subscriber Group. "We see Motorola's mobile devices as bridges to the patient's body, enabling the delivery of care, education, advice, and support remotely and transparently."
MOTOHEALTH has not received FDA approval yet. The product's use is for experimental purposes only and is not to be used with patients with critical conditions. In addition to the MOTOHEALTH programme, Motorola has a partnership with GMP Companies. The two companies partnered on the development of the LifeSync Wireless ECG System, which GMP launched in the United States hospital market in March of this year.
Boston-based Partners Telemedicine, a service of Harvard-affiliated Teaching Hospitals, is part of the international movement to redefine modern health care through innovative applications of communication technologies. A division of Partners Healthcare Inc., Partners Telemedicine focus includes digital home health or telehealth, on-line second opinion consultations, interactive consultations and remote services to underserved population. Research through clinical trials and physician education is the cornerstone of its foundation.
Motorola Inc. is a global expert in wireless, broadband and automotive communications technologies that help make life smarter, safer, simpler, synchronized and fun. Sales in 2003 were U.S.$27,1 billion. Motorola creates innovative technological solutions that benefit people at home, at work and on the move. The company also is a progressive corporate citizen dedicated to operating ethically, protecting the environment and supporting the communities in which it does business.